文献速递小儿眼科与斜弱视白内障与屈光手术

婴幼儿无晶状体眼治疗研究中隐形眼镜依从性与视力结局的关联:一项随机临床试验的二次分析

Association of Contact Lens Adherence With Visual Outcome in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial.
PubMed 文献 · JAMA Ophthalmol · 2018-01-01

该研究为多中心随机临床试验的二次分析,纳入57名2004年8月22日至2008年4月25日出生的单眼白内障术后婴儿,随机接受人工晶状体植入或隐形眼镜矫正无晶状体眼,随访至5岁。通过每3个月一次48小时回忆电话访谈评估隐形眼镜依从性,结果显示各年佩戴率中位数为95%、93%、93%、93%、89%,年龄较大时依从性趋于更差(F=3.86,P<.001);整个研究期间佩戴清醒时间比例更高的儿童在4.5岁时视力趋于更好,但校正遮盖依从性后未达统计学显著(偏相关=-0.026;P=.08)。

要点

  • 第1年隐形眼镜佩戴中位数为95%(IQR 84%-100%),第5年降至89%(IQR 71%-97%),随年龄增长依从性趋于更差(F=3.86,P<.001)。
  • 按性别、保险覆盖或白内障手术年龄分析,依从性未见差异。
  • 整个研究期间佩戴清醒时间比例更高者4.5岁时视力趋于更好,校正遮盖依从性后偏相关=-0.026(P=.08),未达统计学显著。

核心结论

  • 作者认为,这些结果证实儿童在5年期间可以实现高水平的无晶状体眼隐形眼镜依从性。

研究设计与样本

  • 多中心随机临床试验的二次分析,纳入57名2004年8月22日至2004年4月25日出生的婴儿(原文如此,按上下文应为2004年8月22日至2008年4月25日),随机分配至两种治疗之一并随访至5岁。
  • 干预为单眼白内障摘除术后随机接受人工晶状体植入与隐形眼镜矫正无晶状体眼。
  • 依从性通过术后3个月起至5岁每3个月一次的48小时回忆电话访谈评估,以每年2次及以上访谈报告的清醒时间平均百分比估算。
  • 由巡回检查者在患者4.5岁时评估视力。
  • 数据分析于2016年8月9日至2017年12月7日进行。

主要发现

  • 57名随机接受隐形眼镜治疗的婴儿中,32名(56%)为女孩,49名(86%)为白人,共完成872次电话访谈。
  • 各年隐形眼镜佩戴清醒时间中位数:第1年95%(IQR 84%-100%),第2年93%(IQR 85%-99%),第3年93%(IQR 85%-99%),第4年93%(IQR 75%-99%),第5年89%(IQR 71%-97%)。
  • 年龄较大时报告的依从性趋于更差(F=3.86,P<.001)。
  • 按性别、保险覆盖或白内障手术年龄分析,未发现差异。
  • 线性回归显示,整个研究期间佩戴隐形眼镜占清醒时间比例更高的儿童在4.5岁时视力趋于更好,即使校正遮盖依从性后亦然(偏相关=-0.026;P=.08)。

局限性

  • 原文报告4.5岁时视力与隐形眼镜依从性的关联在校正遮盖依从性后偏相关=-0.026、P=.08,未达统计学显著。
  • 原文报告依从性数据来自48小时回忆电话访谈的自我报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although contact lenses have been used for decades to optically correct eyes in children after cataract surgery, there has never been a prospective study looking at contact lens adherence in children with aphakia, to our knowledge. OBJECTIVE: To evaluate contact lens adherence and its association with visual outcome in a cohort of children treated for unilateral cataract surgery. DESIGN, SETTING, AND PARTICIPANTS: Secondary analysis of a multicenter randomized clinical trial of 57 infants born from August 22, 2004, to April 25, 2008, who were randomized to 1 of 2 treatments and followed up to age 5 years. Data analysis was performed from August 9, 2016, to December 7, 2017. INTERVENTIONS: Unilateral cataract extraction and randomization to implantation of an intraocular lens vs contact lens to correct aphakia. MAIN OUTCOMES AND MEASURES: Contact lens adherence was assessed by a 48-hour recall telephone interview that was administered every 3 months starting 3 months after surgery to age 5 years. A traveling examiner assessed visual acuity in patients at aged 4.5 years. Adherence to prescribed contact lens use was estimated as the mean percentage of waking hours as reported in 2 or more interviews for each year of life. RESULTS: Of 57 infants who were randomized to contact lens treatment, 32 (56%) were girls, and 49 (86%) were white. A total of 872 telephone interviews were completed. In year 1, a median of 95% participants wore their contacts lenses nearly all waking hours (interquartile range [IQR], 84%-100%); year 2, 93% (IQR, 85%-99%); year 3, 93% (IQR, 85%-99%); year 4, 93% (IQR, 75%-99%); and year 5, 89% (IQR, 71%-97%). There was a tendency for poorer reported adherence at older ages (F = 3.86, P < .001). No differences were identified when the results were analyzed by sex, insurance coverage, or age at cataract surgery. Using linear regression, children who wore the contact lens for a greater proportion of waking hours during the entire study period tended to have better visual acuity at age 4.5 years, even after accounting for adherence to patching (partial correlation = -0.026; P = .08). CONCLUSIONS AND RELEVANCE: These results confirm that it is possible to achieve a high level of aphakic contact lens adherence over a 5-year period in children. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00212134.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Cromelin CH, Drews-Botsch C, Russell B, et al. Association of Contact Lens Adherence With Visual Outcome in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2018. PMID: 29423513. doi:10.1001/jamaophthalmol.2017.6691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。